HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vanita Noronha Selected Research

nimotuzumab

1/2022Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab.
11/2021Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trial.
10/2021Aspiration pneumonia in head and neck cancer patients undergoing concurrent chemoradiation from India: Findings from a post hoc analysis of a phase 3 study.
5/2021Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis.
12/2020Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
1/2020Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer.
1/2019A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
1/2013Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel and epidermal growth factor receptor monoclonal antibody, nimotuzumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vanita Noronha Research Topics

Disease

47Neoplasms (Cancer)
08/2022 - 01/2012
32Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 01/2014
28Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 01/2013
16Lung Neoplasms (Lung Cancer)
08/2022 - 01/2013
15Squamous Cell Carcinoma of Head and Neck
11/2022 - 03/2015
12Carcinoma (Carcinomatosis)
01/2020 - 11/2005
8Adenocarcinoma
10/2021 - 01/2013
7Disease Progression
08/2022 - 01/2012
6Mouth Neoplasms (Oral Cancer)
01/2022 - 01/2012
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 07/2015
5Adenocarcinoma of Lung
08/2021 - 10/2015
4Brain Neoplasms (Brain Tumor)
01/2022 - 07/2006
4Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2016
4Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2022 - 03/2015
4Prostatic Neoplasms (Prostate Cancer)
10/2021 - 10/2012
4Pain (Aches)
01/2021 - 04/2013
3Fatigue
03/2022 - 07/2017
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2020 - 04/2016
3Hyponatremia
12/2020 - 01/2014
2Thyroid Neoplasms (Thyroid Cancer)
03/2022 - 03/2022
2Esophageal Neoplasms (Esophageal Cancer)
03/2022 - 09/2016
2Weight Loss (Weight Reduction)
11/2021 - 01/2017
2Stomatitis
05/2021 - 01/2018
2Residual Neoplasm
03/2021 - 10/2015
2Mucositis
01/2021 - 01/2018
2Infections
12/2020 - 01/2017
2Anemia
12/2020 - 04/2018
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
03/2020 - 07/2019
2Oropharyngeal Neoplasms
01/2020 - 01/2019
2Fibrosis (Cirrhosis)
01/2018 - 07/2014
2Nausea
08/2017 - 01/2017
2Vomiting
08/2017 - 01/2017
2Breast Neoplasms (Breast Cancer)
07/2006 - 09/2005
1Medullary Carcinoma
03/2022
1Dyspnea (Shortness of Breath)
03/2022
1Extranodal Extension
01/2022
1Cognitive Dysfunction
01/2022
1Aspiration Pneumonia
10/2021
1Cicatrix (Scar)
03/2021
1Necrosis
03/2021
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2021
1Teratoma (Teratoid Tumor)
03/2021
1Testicular Diseases
03/2021

Drug/Important Bio-Agent (IBA)

18Cisplatin (Platino)FDA LinkGeneric
11/2022 - 09/2014
15PlatinumIBA
01/2021 - 09/2012
11Tyrosine Kinase InhibitorsIBA
08/2022 - 01/2013
11ErbB Receptors (EGF Receptor)IBA
03/2022 - 01/2013
10Pemetrexed (MTA)FDA Link
01/2021 - 01/2014
8nimotuzumabIBA
01/2022 - 01/2013
8Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 03/2006
7Carboplatin (JM8)FDA LinkGeneric
01/2021 - 03/2006
6Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2022 - 07/2018
6Docetaxel (Taxotere)FDA Link
01/2022 - 09/2005
5Pharmaceutical PreparationsIBA
08/2022 - 07/2014
5Anaplastic Lymphoma KinaseIBA
01/2021 - 04/2013
5Gefitinib (Iressa)FDA Link
10/2020 - 01/2017
5CrizotinibIBA
10/2019 - 04/2013
4osimertinibIBA
08/2022 - 10/2017
4Immune Checkpoint InhibitorsIBA
10/2021 - 01/2020
4taxaneIBA
03/2020 - 01/2014
4Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 01/2012
4Celecoxib (Celebrex)FDA Link
01/2020 - 01/2012
3Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 09/2014
2DNA (Deoxyribonucleic Acid)IBA
05/2022 - 01/2018
2Sunitinib (Sutent)FDA Link
01/2022 - 01/2016
2pembrolizumabIBA
01/2022 - 01/2021
2NivolumabIBA
01/2021 - 07/2019
2Etoposide (VP 16)FDA LinkGeneric
01/2021 - 10/2015
2Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2020
2lorlatinibIBA
01/2020 - 10/2019
2Biological ProductsIBA
01/2020 - 11/2019
2cabazitaxelFDA Link
12/2017 - 05/2016
2AntiemeticsIBA
08/2017 - 01/2017
2Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
01/2017 - 10/2016
2Cetuximab (Erbitux)FDA Link
01/2017 - 03/2015
2Fluorouracil (Carac)FDA LinkGeneric
09/2014 - 11/2005
1RNA (Ribonucleic Acid)IBA
05/2022
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2022
1Sorafenib (BAY 43-9006)FDA Link
03/2022
1lenvatinibIBA
03/2022
1IodineIBA
03/2022
1Cell-Free Nucleic AcidsIBA
01/2022
1LuciferasesIBA
08/2021
1Polytetrafluoroethylene (Teflon)FDA Link
04/2021

Therapy/Procedure

54Drug Therapy (Chemotherapy)
01/2022 - 11/2005
38Therapeutics
03/2022 - 11/2005
20Radiotherapy
03/2022 - 04/2013
13Neoadjuvant Therapy
01/2022 - 01/2012
9Induction Chemotherapy
03/2020 - 01/2012
7Chemoradiotherapy
01/2022 - 01/2018
4Immunotherapy
03/2022 - 01/2020
4Adjuvant Chemotherapy
01/2022 - 09/2012
4Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 10/2011
3Palliative Care (Palliative Therapy)
01/2021 - 10/2016
3Tracheostomy
01/2021 - 01/2012
2Castration
05/2016 - 10/2012
1Duration of Therapy
03/2022
1Re-Irradiation
01/2022
1Lymph Node Excision (Lymph Node Dissection)
03/2021
1Orchiectomy (Orchidectomy)
03/2021